Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 24:14:1462620.
doi: 10.3389/fcimb.2024.1462620. eCollection 2024.

Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii

Md Minarul Islam #  1   2 , Nasir Uddin Mahbub #  3 , Woo Shik Shin  4 , Man Hwan Oh  1   2   5
Affiliations
Review

Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii

Md Minarul Islam et al. Front Cell Infect Microbiol. .

Abstract

Acinetobacter baumannii, a predominant nosocomial pathogen, represents a grave threat to public health due to its multiple antimicrobial resistance. Managing patients afflicted with severe infections caused by multiple drug-resistant A. baumannii is particularly challenging, given the associated high mortality rates and unfavorable prognoses. The diminishing efficacy of antibiotics against this superbug underscores the urgent necessity for novel treatments or strategies to address this formidable issue. Bacteriophage-derived polysaccharide depolymerase enzymes present a potential approach to combating this pathogen. These enzymes target and degrade the bacterial cell's exopolysaccharide, capsular polysaccharide, and lipopolysaccharide, thereby disrupting biofilm formation and impairing the bacteria's defense mechanisms. Nonetheless, the narrow host range of phage depolymerases limits their therapeutic efficacy. Despite the benefits of these enzymes, phage-resistant strains have been identified, highlighting the complexity of phage-host interactions and the need for further investigation. While preliminary findings are encouraging, current investigations are limited, and clinical trials are imperative to advance this treatment approach for broader clinical applications. This review explores the potential of phage-derived depolymerase enzymes against A. baumannii infections.

Keywords: bacteriophage; biofilm; depolymerase; drug resistance; polysaccharide.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Structure and mechanisms of action of bacteriophage depolymerases: (A) Distribution of depolymerase within the structure of bacteriophages (B) The overarching mechanisms by which depolymerases catalyze polysaccharide degradation involve two fundamental processes: hydrolysis and lysis. During hydrolysis, depolymerases enzymatically cleave the glycosidic bonds between sugar monomers, resulting in the fragmentation of polysaccharides into smaller sugar units. In the lysis process, these enzymes compromise the structural integrity of the polysaccharide matrix. Created with BioRender.com.
Figure 2
Figure 2
Illustration is the trimeric crystal structure of the tail spike protein. (A) gp49 tail spike protein (PDB ID: 6C72) derived from A. baumannii bacteriophage Fri1, a capsular polysaccharide depolymerase (Hydrolase). (B) Gp54 tail spike (PDB ID: 4Y9V) of A baumannii bacteriophage AP22 polysaccharide degrading lyase. Three monomers are marked by different colors. Created with BioRender.com.
Figure 3
Figure 3
The illustration delineates the anti-biofilm mechanisms of phage-encoded depolymerases: (A) Phage-encoded depolymerases impede biofilm formation by degrading the extracellular polysaccharides that protect the bacterial cells within the biofilm. (B) The synergistic application of phage-encoded depolymerases and antibiotics enhances the bactericidal efficacy against A. baumannii biofilms. The depolymerases degrade the extracellular polysaccharide, rendering the bacteria more susceptible to antibiotic treatment. (C) A consortium of phage-encoded depolymerases can effectively dismantle biofilms by degrading the polysaccharide matrix. (D) Phage-encoded depolymerases sensitize bacteria to the host immune response by degrading the protective polysaccharide matrix of biofilms. Created with BioRender.com.
See this image and copyright information in PMC

References

    1. Abdelkader K., Gutierrez D., Latka A., Boeckaerts D., Drulis-Kawa Z., Criel B., et al. . (2022). The specific capsule depolymerase of phage PMK34 sensitizes acinetobacter baumannii to serum killing. Antibiot. (Basel) 11. doi: 10.3390/antibiotics11050677 - DOI - PMC - PubMed
    1. Akoolo L., Pires S., Kim J., Parker D. (2022). The Capsule of Acinetobacter baumannii Protects against the Innate Immune Response. J. Innate Immun. 14, 543–554. doi: 10.1159/000522232 - DOI - PMC - PubMed
    1. Al-Shamiri M. M., Zhang S., Mi P., Liu Y., Xun M., Yang E., et al. . (2021). Phenotypic and genotypic characteristics of Acinetobacter baumannii enrolled in the relationship among antibiotic resistance, biofilm formation and motility. Microb. Pathogen. 155, 104922. doi: 10.1016/j.micpath.2021.104922 - DOI - PubMed
    1. Ambroa A., Blasco L., López M., Pacios O., Bleriot I., Fernández-García L., et al. . (2022). Genomic analysis of molecular bacterial mechanisms of resistance to phage infection. Front. microbiol. 12. doi: 10.3389/fmicb.2021.784949 - DOI - PMC - PubMed
    1. Anyaegbunam N. J., Anekpo C. C., Anyaegbunam Z. K. G., Doowuese Y., Chinaka C. B., Odo O. J., et al. . (2022). The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects. Microbiol. Res. 264, 127155. doi: 10.1016/j.micres.2022.127155 - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources